Atualização do abaixo-assinadoSign Now: Demand that the FDA Approves Clinical Trials for Plant-Based Baby Formula
Campaign Update: Else Nutrition CEO Urges FDA to Act Now in Washington Times Op-Ed

Else NutritionOH, Estados Unidos

26 de mai. de 2025
In a bold op-ed published in The Washington Times, Else Nutrition CEO and co-founder Hamutal Yitzhak makes a passionate case for urgent FDA approval of clinical trials for plant-based infant formula.
This is a pivotal moment in our fight to give all babies access to clean, sustainable nutrition.
Read it. Share it. Join the movement.
👉 Read the full article and share the news:
Apoie já
Assinar este abaixo-assinado